BiOM has raised $6 million through a debt and equity financing, according to regulatory filing with the Federal Securities and Exchange Commission.
The Bedford, Mass.-based BiOM (formerly known as iWalk) listed 18 investors in the Dec. 23rd filing, including an unnamed "non-U.S. purchaser." which invested a total of $1,079,160 into the bionics prosthetics maker. The company is looking to raise up to $10 million in this round.